NCT01422291COMPLETEDanonymous

Pamukkale University Medical School,Dept. of Emergency Medicine

Sponsor

Source record

Pamukkale University

Phase

Source record

PHASE4

Modality

AI-normalized

small molecule

Target

AI-normalized

paracetamol, morphine, Dexketoprofen, Paracetamole

Indication / condition

AI-normalized

Low Back Pain

Intervention

Source record

paracetamol, morphine, Dexketoprofen, Paracetamole

Related intelligence directories

Indication directory: Low Back Pain Modality directory: small molecule Target directory: paracetamol

Source & freshness

Source record

NCT ID

NCT01422291

Original source

ClinicalTrials.gov

Source last updated

Aug 23, 2011

Ingested at

Jun 09, 2026

Internal sync

Jun 09, 2026

Model version

trialsignal-ai-v1

Normalized confidence

96%

Validation status

validated

Open original registry record

View original source fields

NCT ID

NCT01422291

Title

Pamukkale University Medical School,Dept. of Emergency Medicine

Sponsor

Pamukkale University

Status

COMPLETED

Phase

PHASE4

Condition raw

Low Back Pain

Condition normalized

Low Back Pain

Modality raw

small molecule

Modality normalized

small molecule

Target raw

paracetamol, morphine, Dexketoprofen, Paracetamole

Target normalized

paracetamol, morphine, Dexketoprofen, Paracetamole

Interventions

paracetamol, morphine, Dexketoprofen, Paracetamole

Public preview

Source record

This randomized, controlled trial evaluates the analgesic efficacy and safety of intravenous single-dose paracetamol, dexketoprofen and morphine for the treatment of low back pain.

AI-generated analysis supports research triage only. Verify source records, publications, sponsor disclosures and IP databases before making diligence decisions. Model: trialsignal-ai-v1.

Report access

Create an account to unlock this report

Choose the access model that matches the job: one urgent report, reusable credits for project work, or unlimited monthly access with AI and folders.

Early access offer

Subscribe with code FOUNDERS5 for a 5-day premium trial.

Full protocol, outcomes, eligibility, contacts and results sections

Patent/IP landscape with verified records when available

Board-ready PDF export with source provenance

Save to folders and synthesize multiple assets in premium workspace

Create account

Create a free account first, then unlock a single report, buy credits or subscribe.

TrialSignal

Clinical trial intelligence report

Pamukkale University Medical School,Dept. of Emergency Medicine

Source-linked diligence brief with registry provenance, taxonomy normalization and premium analytical context.

Generated

Jun 20, 2026

NCT ID

NCT01422291

Status

COMPLETED

Phase

PHASE4

Sponsor

Pamukkale University

Executive brief

Investment-Ready Snapshot

This randomized, controlled trial evaluates the analgesic efficacy and safety of intravenous single-dose paracetamol, dexketoprofen and morphine for the treatment of low back pain.

Source & freshness

Provenance

SourceClinicalTrials.gov

Source updatedAug 23, 2011

Internal syncJun 09, 2026

Model versiontrialsignal-ai-v1

https://clinicaltrials.gov/study/NCT01422291

Indication

Low Back Pain

Modality

small molecule

Target

paracetamol, morphine, Dexketoprofen, Paracetamole

Intervention

paracetamol, morphine, Dexketoprofen, Paracetamole

Source record

Protocol Description

Detailed source ingestion pending.

Source record

Outcome Measures

Detailed source ingestion pending.

Source record

Eligibility

Detailed source ingestion pending.

AI analysis

Known Results And Readout Context

Detailed source ingestion pending.

IP intelligence

Patent And IP Landscape

Detailed source ingestion pending.

Source record

Contacts

Detailed source ingestion pending.